Post by Gilead Sciences
836,004 followers
When it comes to metastatic triple-negative breast cancer (mTNBC), innovation cannot wait. Hear what oncologists, researchers, and advocates have to say about why advancing treatment options for metastatic TNBC is so critical.
Video Content